Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

Domo today announced Agent Catalyst, the newest addition to Domo AI, the company's award-winning lineup of cutting-edge AI solutions and tools. Built on top of Domo AI's secure and private platform, ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

Wendy's aims to add some sizzle to its stock price this year. PepsiCo (NASDAQ: PEP) is a company with more than 50 consecutive annual dividend increases under its belt. It requires having a strong ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to ...

The conference call and the slides of the presentation will be webcast live here. In order to receive the conference access information necessary to join the conference call, it is required to ...